Home » Topics » BioWorld Science

BioWorld Science
RSS

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Preclinical results for DC101 presented at AACR

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Topotecan approval recommended

April 26, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Positive results reported in AllerVax Ragweed trials

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...